MYCN and MYC play a crucial role in determining the malignancy of unfavorable neuroblastomas (3,21–23), whereas high-level expression of favorable neuroblastoma genes is associated with a good disease outcome and confers growth suppression of neuroblastoma cells (24). The gene discussed is MYCN; the disease is neuroblastoma.